Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27241889)

Published in Cardiovasc Ther on October 01, 2016

Authors

Vrushali Deshpande1, Rameshkumar Krishnan1, Sheena Philip1, Ildiko Faludi2, Thiruvelselvan Ponnusamy3, Lakshmi Narasimha Rao Thota3, Valeria Endresz2, Xinjie Lu4, Vijay V Kakkar1,4, Lakshmi A Mundkur5

Author Affiliations

1: Molecular Immunology, Thrombosis Research Institute, Bangalore, India.
2: Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.
3: Manipal University at Thrombosis Research Institute, Bangalore, India.
4: Molecular Immunology, Thrombosis Research Institute, London, UK.
5: Molecular Immunology, Thrombosis Research Institute, Bangalore, India. lakshmi.mundkur@triindia.org.in.